Advances in Urothelial Carcinoma: Expert Insights to Guide Clinical Practice

Download All
Gain interdisciplinary perspectives on optimal management of patients with advanced urothelial carcinoma with these downloadable slides, expert commentary, and short virtual presentations, as well as an updated decision support tool.
person default
Arjun Balar, MD
person default
Kaitlyn Francese, MSN, RN, OCN

Downloadable Slidesets

Download slides by Arjun Balar, MD on the role of immunotherapy and chemotherapy as first-line treatment for patients with advanced urothelial cancer.

person default Arjun Balar, MD Released: May 6, 2021

Download slides by Arjun Balar, MD on the role of antibody-drug conjugates in advanced urothelial cancer following chemotherapy and immunotherapy.

person default Arjun Balar, MD Released: May 4, 2021

Download slides by Arjun Balar, MD on the role of biomarkers in urothelial cancer management and selection for treatment approaches.

person default Arjun Balar, MD Released: April 21, 2021

Download slides by Arjun Balar, MD on the role of immunotherapy in early stage urothelial cancer.

person default Arjun Balar, MD Released: April 23, 2021

Download slides by Kaitlyn Francese, MSN, RN, OCN on the optimal management of immune-related AEs for patients with advanced urothelial cancer who are treated with immune checkpoint inhibitor therapy.

person default Kaitlyn Francese, MSN, RN, OCN Released: May 28, 2021

Download slides by Kaitlyn Francese, MSN, RN, OCN on considerations from patients’ perspectives for available treatment strategies for patients with advanced urothelial cancer.

person default Kaitlyn Francese, MSN, RN, OCN Released: May 28, 2021

Gain key clinical insights fast, with this short slideset from CCO on the current and emerging treatment options for patients with bladder cancer.

person default Arjun Balar, MD person default Kaitlyn Francese, MSN, RN, OCN Released: June 2, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue